methaqualone

(redirected from Somnomed)
Also found in: Thesaurus, Medical.

meth·a·qua·lone

 (mĕth′ə-kwā′lōn′)
n.
A potentially habit-forming drug, C16H14N2O, formerly used as a sedative and hypnotic.

[meth(yl) + qu(in)a(zo)l(inon), a derivative of quinoline + -one.]

methaqualone

(ˌmɛθəˈkweɪləʊn)
n
(Pharmacology) a nonbarbituate sedative drug used to treat stress and insomnia. Formula: C16H14N2O. US proprietary name: Quaalude

me•tha•qua•lone

(məˈθæk wəˌloʊn, ˌmɛθ əˈkweɪ loʊn, -ˈkwɒl oʊn)

n.
a nonbarbiturate sedative-hypnotic substance, C16H14N2O, used to induce sleep.
[1960–65; meth (yl) + -a- + qu(in)a(zo)l(in)one=quinazoline (< German Chinazolin, alter. of Chinolin quinoline) + -one]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.methaqualone - sedative-hypnotic drug (trade name Quaalude) that is a drug of abuse
sedative-hypnotic, sedative-hypnotic drug - a sedative that depresses activity of the central nervous system and reduces anxiety and induces sleep
Translations

methaqualone

n metacualona
References in periodicals archive ?
12 November 2015 - Australian sleep treatment oral device maker SomnoMed Ltd.
SOMNOMED MAS: It is a Mandibular Advancement Splint (MAS) that treats both snoring and obstructive sleep apnea (OSA), by positioning the lower jaw forward.
Sydney, Australia, Oct 18, 2013 - (ABN Newswire) - SomnoMed Limited (ASX:SOM) (OTCMKTS:SOMNF) announced today the expansion of its business in the Republic of Korea, following the registration by the Korean FDA of SomnoDent(R) as an accepted medical device for the treatment of obstructive sleep apnea.